The effect of glucose added to dialysis fluid on blood pressure, blood glucose and quality of life in hemodialysis patients. A placebo controlled cross-over study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN53978980

Enrollment

Registered

2006-01-26

Start date

2003-05-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure Nutritional, Metabolic, Endocrine Chronic renal failure

Interventions

Glucose versus placebo The purpose of the study was to determine the effect of glucose added to the dialysis fluid on: 1. Blood pressure and variation in blood pressure 2. Blood glucose and variati

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age more than 18 years, both men and women, and hemodialysis treatment for more than three months

Exclusion criteria

Exclusion criteria: 1. Treatment with hemodiafiltration 2. Change to another dialysis modality 3. Renal transplantation 4. Alcohol abuse defined as more than 21 units a week for men and more than fourteen units a week for women 5. Unwillingness to participate

Design outcomes

Primary

Measure	Time frame
Blood pressure, blood glucose, quality of life	—

Secondary

Measure	Time frame
Blood pressure variability, blood glucose variability	—

Countries

Denmark

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026